Skip to main content

Main menu

  • Home
  • Our journals
    • Clinical Medicine
    • Future Healthcare Journal
  • Subject collections
  • About the RCP
  • Contact us

Clinical Medicine Journal

  • ClinMed Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Author guidance
    • Instructions for authors
    • Submit online
  • About ClinMed
    • Scope
    • Editorial board
    • Policies
    • Information for reviewers
    • Advertising

User menu

  • Log in

Search

  • Advanced search
RCP Journals
Home
  • Log in
  • Home
  • Our journals
    • Clinical Medicine
    • Future Healthcare Journal
  • Subject collections
  • About the RCP
  • Contact us
Advanced

Clinical Medicine Journal

clinmedicine Logo
  • ClinMed Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Author guidance
    • Instructions for authors
    • Submit online
  • About ClinMed
    • Scope
    • Editorial board
    • Policies
    • Information for reviewers
    • Advertising

Breaking the barrier – a novel approach to controlling infection in hard-to-heal wounds

Graham Dixon
Download PDF
DOI: https://doi.org/10.7861/clinmedicine.19-2-s93
Clin Med March 2019
Graham Dixon
R&D, Neem Biotech Ltd, Abertillery, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Aims

This study aimed to evaluate anti-biofilm and wound healing effects of NX-AS-911 in an ex vivo wound model infected with ‘gold standard’ Pseudomonas aeruginosa and Staphylococcus aureus in the presence (and absence) of standard of care (SOC) antibiotics.

Methods

The anti-biofilm effects of NX-AS-911 on S aureus and
P aeruginosa in the presence (and absence) of SOC antibiotics were reviewed by inoculating artificial wounds 24- to 48-hours prior to a 3-day, daily treatment regime with NX-AS-911 in the presence and absence of SOC antibiotics. Sampling was performed day-2 and day-4 post initiating treatment. Analysis on the effect on total bioburden was performed through colony-forming units (CFU) determinations, followed by a review of the effects on pathogen and host gene expression through quantitative RT-PCR. Immuno-histochemical staining and microscopy were performed to evaluate the extent of epithelialisation/wound healing and presence of biofilm aggregates and inflammatory markers. Time points were day-4 and day-7 post initiating treatment.

Results

Treatment with NX-AS-911 increased the ex vivo efficacy of SOC antibiotics against S aureus and P aeruginosa biofilms. Expression of key pathogen virulence genes was reduced in the presence of NX-AS-911. Combination treatment also showed evidence of wound healing due to the reduction in pathogen virulence factor expression and bioburden and NX-AS-911 had an immuno-modulatory effect.

Conclusion

NX-AS-911 has anti-virulence activity against both S aureus and P aeruginosa. NX-AS-911 also enhanced the antibiotic activity of SOC antibiotics against clinically relevant strains of S aureus and P aeruginosa, supporting our efforts to progress this drug to clinical evaluation as an adjunctive therapy to conventional antibiotics in the treatment of chronic wound infections and cystic fibrosis.

Conflict of interest statement

There is no conflict of interest.

  • © Royal College of Physicians 2019. All rights reserved.
Back to top
Previous articleNext article

Article Tools

Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Breaking the barrier – a novel approach to controlling infection in hard-to-heal wounds
Graham Dixon
Clinical Medicine Mar 2019, 19 (Suppl 2) 93; DOI: 10.7861/clinmedicine.19-2-s93

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Breaking the barrier – a novel approach to controlling infection in hard-to-heal wounds
Graham Dixon
Clinical Medicine Mar 2019, 19 (Suppl 2) 93; DOI: 10.7861/clinmedicine.19-2-s93
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Aims
    • Methods
    • Results
    • Conclusion
    • Conflict of interest statement
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Taking back control: a better deal for junior doctor engagement in rota design using e-Delphi and Assignment Problem Algorithm
  • Formation of a Junior Doctor Wellbeing Steering Group
  • Developing an acute oncology support smartphone app for Wales
Show more Research and innovation

Similar Articles

Navigate this Journal

  • Journal Home
  • Current Issue
  • Ahead of Print
  • Archive

Related Links

  • ClinMed - Home
  • FHJ - Home
clinmedicine Footer Logo
  • Home
  • Journals
  • Contact us
  • Advertise
HighWire Press, Inc.

Follow Us:

  • Follow HighWire Origins on Twitter
  • Visit HighWire Origins on Facebook

Copyright © 2021 by the Royal College of Physicians